Digital plaster enters clinical trials
A specialist clinical research team at Imperial College London has begun clinical trials of Toumaz Technology's Sensium 'digital plaster'. The study, which is being conducted at St Mary's Hospital, is expected to demonstrate the high quality physiological data that can be continuously acquired by wireless.
In the trial, volunteers and patient groups will be fitted with a wearable Sensium device to monitor multiple vital signs, including temperature, heart rate and respiration. The focus of the trial will be to verify that data acquired via Sensium is equivalent to that acquired using current hospital monitors.
Toumaz' founder Professor Chris Toumazou said: "It is fantastic to see Sensium technology coming to commercial fruition. This is a key stage in our commercial journey and one that opens the door to some very exciting applications of our technology in clinical environments next year."
